Jeffrey Dierks - Sep 7, 2021 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role
Chief Commercial Officer
Signature
/s/ Christian Ulrich, Attorney-in-fact for Jeffrey Dierks
Stock symbol
HRMY
Transactions as of
Sep 7, 2021
Transactions value $
-$143,900
Form type
4
Date filed
9/9/2021, 09:34 PM
Previous filing
Sep 3, 2021
Next filing
Nov 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRMY Common Stock Options Exercise $41.1K +5K $8.22* 5K Sep 7, 2021 Direct
transaction HRMY Common Stock Sale -$185K -5K -100% $37.00 0 Sep 7, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRMY Stock Option Options Exercise $0 -4.08K -35.86% $0.00 7.3K Sep 7, 2021 Common Stock 4.08K $8.22 Direct F2, F4
transaction HRMY Stock Option Options Exercise $0 -917 -3.77% $0.00 23.4K Sep 7, 2021 Common Stock 917 $8.22 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The stock option is currently vested with respect to 4,868 shares, and will vest with respect to the remainder of the shares in three equal annual installments beginning on October 1, 2021.
F3 The stock option is currently vested with respect to 4,869 shares, and will vest with respect to the remainder of the shares in four equal annual installments beginning on March 1, 2022.
F4 Reflects the exercise of 785 stock options on September 1, 2021, which was reported on the Form 4 filed by the reporting person on September 3, 2021, but erroneously reflected as an exercise of the tranche which expires on October 2, 2027, rather than the tranche which expires on October 1, 2028.